Physician profile
John Mitchell
NPI 1417975186
$2,344.34
in general payments reported to CMS, 2019-2025
16 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $205 · 2021: $446 · 2022: $381 · 2023: $180 · 2024: $326 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,068.46 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $385.36 | 2021-2025 | Symplicity G3, Onyx Frontier, Linq II |
| E.R. Squibb & Sons, L.L.C. | $206.25 | 2022-2024 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $161.49 | 2020-2023 | Opsumit, Uptravi |
| Philips North America LLC | $157.20 | 2023-2025 | Coronary Other, (Cm9) Amb Mon & Diag Und |
| Abbott Laboratories | $116.53 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $52.53 | 2019-2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $30.14 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $29.13 | 2021-2022 | |
| Welch Allyn | $27.60 | 2019 | |
| Siemens Medical Solutions USA, INC. | $24.87 | 2019-2020 | |
| Heartflow, INC. | $24.36 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $19.01 | 2023 | Inpefa |
| Impulse Dynamics (USA) INC. | $16.33 | 2023 | Optimizer |
| Amgen INC. | $14.26 | 2025 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $10.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.